Zhongchao Inc. (ZCMD)
NASDAQ: ZCMD · Real-Time Price · USD
0.9906
-0.0294 (-2.88%)
Nov 2, 2026, 9:35 AM EST - Market open
Zhongchao Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 6.61 | 11.37 | 15.86 | 19.43 | 14.15 | 16.3 |
Revenue Growth | -41.85% | -28.30% | -18.37% | 37.33% | -13.16% | -9.41% |
Gross Profit Gross Profit Growth | 2.47 | 5.12 | 8.91 | 8.51 | 6.36 | 9.44 |
Operating Income Operating Income Growth | -9.73 | -6.19 | -0.34 | -5.41 | -2.95 | -0.32 |
Net Income Net Income Growth | -10.64 | -6.31 | -0.64 | -11.34 | -2.94 | 0.24 |
Earnings Per Share EPS Growth | -164.19 | -343.35 | - | - | - | - |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
MDMOOC Services MDMOOC Services Growth | 10.68 | 10.68 | 13.71 | 10.41 | 12.94 | 16.3 |
Sales of Patented Drugs Sales of Patented Drugs Growth | 0.7 | 0.7 | 2.15 | 9.03 | 1.22 | - |
Total Total Growth | 11.37 | 11.37 | 15.86 | 19.43 | 14.15 | 16.3 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 17.34 | 13.92 | 13.08 | 13.45 | 12.04 | 14.21 |
Total Debt Total Debt Growth | - | 0.03 | 0.06 | 0.81 | 1.7 | 0.2 |
Net Cash (Debt) Net Cash Growth | 17.34 | 13.9 | 13.03 | 12.64 | 10.34 | 14.01 |
Net Cash Growth | 24.80% | 6.68% | 3.07% | 22.27% | -26.22% | -17.80% |
Net Cash Per Share Net Cash Per Share Growth | 267.56 | 756.15 | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -2.5 | 0.85 | -1.47 | 0.05 | -0.66 | 2.86 |
Capital Expenditures CapEx Growth | -0.15 | -0.15 | -3.05 | -0.84 | -1.86 | -1.8 |
Free Cash Flow Free Cash Flow Growth | -2.66 | 0.69 | -4.52 | -0.79 | -2.52 | 1.06 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 37.30% | 45.02% | 56.18% | 43.80% | 44.92% | 57.92% |
Operating Margin | -147.09% | -54.43% | -2.15% | -27.84% | -20.88% | -1.97% |
Pretax Margin | -159.18% | -50.71% | 0.39% | -61.63% | -18.02% | -0.68% |
Profit Margin | -160.90% | -55.47% | -4.05% | -58.33% | -20.78% | 1.46% |
FCF Margin | -40.17% | 6.09% | -28.48% | -4.04% | -17.83% | 6.52% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 186.00 |
P/FCF Ratio | - | 19.97 | - | - | - | 41.80 |
PS Ratio | 0.68 | 1.22 | 2.58 | 0.47 | 2.11 | 2.72 |